title: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
authors.affiliation: Klinikum der Ludwig Maximilians Universität, Munich, Germany michael.fischereder@med.uni-muenchen.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Fischereder
authors.affiliation: Klinikum der Ludwig Maximilians Universität, Munich, Germany michael.fischereder@med.uni-muenchen.de.
authors.forename: Ulf
authors.initials: U
authors.lastname: Schönermarck
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents